Prenatal Blood Test May Detect Cancer in Mothers
Unexpected Discovery: Prenatal Blood Test Can Sometimes Detect Cancer in Moms-to-Be
A routine prenatal blood test designed to screen for fetal abnormalities may hold an unexpected benefit: the early detection of cancer in pregnant women.
While primarily used to check for conditions like Down syndrome, cell-free DNA sequencing tests can sometimes reveal unusual results that hint at the presence of cancer in the mother.A recent study published in the New England Journal of Medicine sheds light on this surprising finding.
Researchers at the National Institutes of Health (NIH) studied 107 pregnant women who received unusual results from their cell-free DNA tests.
“They looked like healthy, young women and they reported themselves as being healthy,” said Dr. Diana Bianchi, the study’s senior author and director of the National Institute of Child Health and Human Development.
Shockingly, 52 of these women were ultimately diagnosed with cancer.
The most common types of cancer detected were lymphoma, colon cancer, and breast cancer.
test1733381451296_1733381451675.jpg” alt=”The blood test is called cell-free DNA sequencing.(Pexels)” title=”The blood test is called cell-free DNA sequencing.(Pexels)”>A Rare but Important Finding
While millions of pregnant women undergo cell-free DNA testing each year, only a small fraction (about 1 in 10,000) receive results that are difficult to interpret. This small group, potentially numbering around 250 women annually in the U.S., might potentially be at risk for cancer.
“They and their care providers need to take the results seriously and have additional testing because in that population there is a 48% risk of cancer,” Dr. Bianchi emphasized.
The study recommends that women with these unusual test results undergo a whole-body MRI scan to investigate further.
Moving Forward: Awareness and Access
The NIH study is ongoing, aiming to identify more specific indicators that could help determine which women should be screened for cancer.
Dr. neeta Vora,director of reproductive genetics at the University of North Carolina at Chapel Hill,who wrote an editorial accompanying the study,highlighted the importance of educating doctors about this rare but significant finding.
“Doctors who care for pregnant women are not accustomed to ordering whole-body MRI tests,” dr. Vora noted, adding that these scans can be expensive and may not be covered by insurance.
This discovery underscores the need for increased awareness among healthcare providers and expectant mothers alike. While cell-free DNA testing remains a valuable tool for detecting fetal abnormalities, it may also offer an unexpected prospect for early cancer detection in pregnant women.
Prenatal Blood Test: A Surprise Find for Moms-to-Be
Hoping for a healthy baby lies at the heart of every pregnancy.Now, a routine prenatal blood test may offer expectant mothers more than just peace of mind about their baby’s health. A recent study published in the New England journal of Medicine reveals a surprising benefit: the potential to detect cancer in pregnant women.
Traditionally used to screen for fetal abnormalities like Down syndrome, cell-free DNA sequencing tests analyze fragments of fetal DNA circulating in the mother’s blood. But what happens when the results reveal unexpected findings?
The NIH study, led by Dr. Diana Bianchi, delved into this question by following 107 pregnant women who received unusual results from their cell-free DNA tests. The results were staggering: 52 of these seemingly healthy women were ultimately diagnosed with cancer.
The types of cancers detected varied, with lymphoma, colon cancer, and breast cancer being the most common.
While millions of pregnant women undergo cell-free DNA testing annually, only a small percentage—approximately 1 in 10,000—receive ambiguous results.
Dr. Bianchi stresses the importance of taking these results seriously: “They and their care providers need to take the results seriously and have additional testing because in that population there is a 48% risk of cancer.”
The study recommends a whole-body MRI scan for further investigation in these cases.
This groundbreaking finding underscores the need for heightened awareness among both healthcare providers and expectant mothers.
Dr. Neeta vora, a reproductive geneticist at the University of North Carolina at Chapel Hill, emphasizes the importance of educating doctors about this rare but significant finding. “Doctors who care for pregnant women are not accustomed to ordering whole-body MRI tests,” she notes, pointing out the potential for cost and insurance coverage issues.
While further research is needed to identify more specific indicators for cancer screening, this unexpected benefit of cell-free DNA testing highlights the potential for early detection and intervention, offering a glimmer of hope for both mothers and their unborn children.